Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 22 February 2021. Alex Gorsky.

Executive Summary

The four major orthopedic companies have seen significant reductions in fourth-quarter revenues due to the delay of elective procedures amid the resurgence of COVID-19 cases. See what Johnson & Johnson’s CEO Alex Gorsky said about it here.

“The knee market was perhaps hit more than others, just because many of those procedures can be delayed perhaps versus a hip procedure. But we would expect that to return over the course of this year, as we see the pandemic dealt with in a more effective way and things hopefully return to a more normal state.” – Alex Gorsky, CEO, Johnson & Johnson

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts